Abstract
Fragile X syndrome (FXS) is caused by the expansion of a CGG repeat in the 5′UTR of the FMR1 gene and the subsequent methylation of all CpG sites in the promoter region. We recently identified, in unrelated FXS families, two rare males with an unmethylated full mutation, that is, with an expanded CGG repeat (>200 triplets) lacking the typical CpG methylation in the FMR1 promoter. These individuals are not mentally retarded and do not appear to be mosaic for premutation or methylated full mutation alleles. We established lymphoblastoid and fibroblast cell lines that showed essentially normal levels of the FMR1-mRNA but reduced translational efficiency of the corresponding mRNA. Epigenetic analysis of the FMR1 gene demonstrated the lack of DNA methylation and a methylation pattern of lysines 4 and 27 on histone H3 similar to that of normal controls, in accordance with normal transcription levels and consistent with a euchromatic configuration. On the other hand, histone H3/H4 acetylation and lysine 9 methylation on histone H3 were similar to those of typical FXS cell lines, suggesting that these epigenetic changes are not sufficient for FMR1 gene inactivation. These findings demonstrate remarkable consistency and suggest a common genetic mechanism causing this rare FMR1 epigenotype. The discovery of such a mechanism may be important in view of therapeutic attempts to convert methylated into unmethylated full mutations, restoring the expression of the FMR1 gene.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Verkerk AJ, Pieretti M, Sutcliffe JS et al: Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65: 905–914.
Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D et al: Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X Study: preliminary data. Am J Med Genet 1999; 83: 322–325.
Hagerman RJ, Leehey M, Heinrichs W et al: Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001; 57: 127–130.
Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ : Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile X syndrome. Am J Hum Genet 2000; 66: 6–15.
Oberle' I, Rousseau F, Heitz D et al: Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991; 252: 1097–1102.
Pieretti M, Zhang F, Fu YH et al: Absence of expression of the FMR1 gene in fragile X syndrome. Cell 1991; 66: 817–822.
Sutcliffe JS, Nelson DL, Zhang F et al: DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1992; 1: 397–400.
Bestor TH : The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395–2402.
Kress C, Thomassin H, Grange T : Local DNA demethylation in vertebrates: how could it be performed and targeted? FEBS Lett 2001; 494: 135–140.
Lee KK, Workman JL : Histone acetyltransferase complexes: one size doesn't fit all. Nat Rev Mol Cell Biol 2007; 8: 284–295.
Yang XJ, Seto E : HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007; 26: 5310–5318.
Yang XJ, Seto E : Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr Opin Genet Dev 2003; 13: 143–153.
Zaratiegui M, Irvine DV, Martienssen RA : Noncoding RNAs and gene silencing. Cell 2007; 128: 763–776.
Lachner M, O'Sullivan RJ, Jenuwein T : An epigenetic road map for histone lysine methylation. J Cell Sci 2003; 116: 2117–2124.
Shi Y : Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev 2007; 8: 829–833.
Shi Y, Whetstine JR : Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007; 25: 1–14.
Nishioka K, Chuikov S, Sarma K et al: Set9, a novel histone H3 ethyltransferase that facilitates transcription by precluding histone tail modifications require for heterochromatin formation. Genes Dev 2002; 16: 479–489.
Li E : Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3: 662–673.
Grewal SIS, Moazed D : Heterochromatin and epigenetic control of gene expression. Science 2003; 301: 798–802.
Vakoc CR, Mandat SA, Olenchock BA, Blobel GA : Histone H3 lysine 9 methylation and HP1γ are associated with transcription elongation through mammalian chromatin. Mol Cell 2005; 19: 381–391.
Yasuhara JC, Wakimoto BT : Oxymoron no more: the expanding world of heterochromatic genes. Trends Genet 2006; 22: 330–338.
Matzke MA, Birchler JA : RNAi-mediated pathways in the nucleus. Nature Rev Genet 2005; 6: 24–35.
Sparmann A, van Lohuizen M : Polycomb silencers control cell fate, development and cancer. Nature Rev Cancer 2006; 6: 846–856.
Lee MG, Villa R, Trojer P et al: Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007; 318: 447–450.
Coffee B, Zhang F, Warren S, Reines D : Acetylated histones are associated with FMR1 in normal but not fragile X syndrome cells. Nature Genet 1999; 22: 98–101.
Coffee B, Zhang F, Ceman S, Warren S, Reines D : Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile X syndrome. Am J Hum Genet 2002; 71: 923–932.
Pietrobono R, Tabolacci E, Zalfa F et al: Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum Mol Genet 2005; 14: 267–277.
Chiurazzi P, Pomponi MG, Pietrobono R, Bakker CE, Neri G, Oostra BA : Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum Mol Genet 1999; 8: 2317–2323.
Smeets HJ, Smits AP, Verheij CE et al: Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 1995; 4: 2103–2108.
Brouwer JR, Mientjesa EJ, Bakker CE et al: Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 2007; 313: 244–253.
Eiges R, Urbach A, Malcov M et al: Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007; 1: 568–577.
Tabolacci E, Pietrobono R, Moscato U, Oostra BA, Chiurazzi P, Neri G : Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur J Hum Genet 2005; 13: 641–648.
Pietrobono R, Pomponi MG, Tabolacci E, Oostra BA, Chiurazzi P, Neri G : Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res 2002; 30: 3278–3285.
Tabolacci E, Pomponi MG, Pietrobono R, Chiurazzi P, Neri G : A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy. Eur J Hum Genet 2007; 16: 209–214.
Wohrle D, Salat U, Hameister H, Vogel W, Steinbach P : Demethylation reactivation, and destabilization of human fragile X full mutation alleles in mouse embryocarcinoma cells. Am J Hum Genet 2001; 69: 504–515.
Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ : Fragile X males with unmethylated full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 2000; 94: 232–236.
Feng Y, Zhang F, Lokey LK et al: Translational suppression by trinucleotide repeat expansion at FMR1. Science 1995; 268: 731–734.
Tassone F, Hagerman RJ, Taylor AK et al: Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 2000; 91: 144–152.
Khateb S, Weisman-Shomer P, Hershco-Shani I, Ludwig AL, Fry M : The tetraplex (CGG)n destabilizing proteins hnRNP A2 and CBF-A enhance the in vivo translation of fragile X premutation mRNA. Nucleic Acids Res 2007; 35: 5775–5788.
Taylor AK, Tassone F, Dyer PN et al: Tissue heterogeneity of the FMR1 mutation in a high-functioning male with Fragile X syndrome. Am J Med Genet 1999; 84: 233–239.
Litt MD, Simpson M, Gaszner M, Allis CD, Felsenfeld G : Correlation between histone lysine methylation and development changes at the chicken beta-globin locus. Science 2001; 293: 2453–2455.
Zofall M, Grewal SI : Swi6/HP1 recruits a JmjC domain protein to facilitate transcription of heterochromatic repeats. Mol Cell 2006; 22: 681–692.
Grewal SIS, Jia S : Heterochromatin revisited. Nat Rev 2007; 8: 35–46.
Fuks F, Hurd PJ, Wold D, Nan X, Bird AP, Kouzarides T : The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 2003; 278: 4035–4040.
Motamedi MR, Verdel A, Colmenares SU, Gerber SA, Gygi SP, Moazed D : Two RNAi complexes, RITS and RDRC, physically interact and localize to noncoding centromeric RNAs. Cell 2004; 119: 789–802.
Handa V, Saha T, Usdin K : The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res 2003; 31: 6243–6248.
Hong EE, Villen J, Gerace EL, Gygi SP, Moazed DA : Cullin E3 ubiquitin ligase complex associates with Rik1 and the Clr4 histone H3-K9 methyltransferase and is required for RNAi-mediated heterochromatin formation. RNA Biol 2005; 2: 106–111.
Cao R, Wang L, Wang H et al: Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 2002; 298: 1039–1043.
Acknowledgements
We gratefully acknowledge the financial support of Telethon Foundation (GGP06224), PRIN 2005 (Grant no. 2005060575) and Conquer Fragile X Foundation to GN.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)
Supplementary information
Rights and permissions
About this article
Cite this article
Tabolacci, E., Moscato, U., Zalfa, F. et al. Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur J Hum Genet 16, 1487–1498 (2008). https://doi.org/10.1038/ejhg.2008.130
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2008.130
Keywords
This article is cited by
-
Methylated premutation of the FMR1 gene in three sisters: correlating CGG expansion and epigenetic inactivation
European Journal of Human Genetics (2020)
-
Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene
Human Genetics (2020)
-
Recent advances in assays for the fragile X-related disorders
Human Genetics (2017)
-
Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Epigenetics & Chromatin (2016)
-
Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome
Clinical Epigenetics (2016)
